NCT00003636 Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE3
NCT00003634 Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy Status UNKNOWN Phase PHASE2
NCT00003624 Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer Status TERMINATED Phase PHASE2
NCT00003569 Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel Status COMPLETED Phase N/A
NCT00003560 Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status UNKNOWN Phase PHASE2
NCT00003523 Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum Status COMPLETED Phase PHASE2
NCT00003518 Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00003450 Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00003449 Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00003425 Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect Status COMPLETED Phase PHASE1/PHASE2
NCT00003413 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer Status COMPLETED Phase PHASE2
NCT00003408 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Status COMPLETED Phase PHASE2
NCT00003386 Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer Status TERMINATED Phase PHASE2
NCT00003385 Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT00003382 Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer Status TERMINATED Phase PHASE1
NCT00003380 Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer Status TERMINATED Phase PHASE1
NCT00003378 Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer Status TERMINATED Phase PHASE1
NCT00003358 Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00003345 Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer Status COMPLETED Phase PHASE2